WELCOME TO
BSG LIVE’25
Connect • Learn • Innovate
Industry Symposia – Madrigal Pharmaceuticals
MASH in clinical practice: What is the impact and how to identify at-risk patients?
Thursday 26 June 12:50-13:20
The objective of this non-promotional symposium is to educate the audience on metabolic dysfunction-associated steatohepatitis (MASH) and to increase the awareness of the audience on:
- The burden of the disease
- How to identify patient with MASH consistent with F2-F3 based on local guidelines
Speakers:
Dr Daniel Forton, St George’s University Hospitals NHS Foundation Trust.
Dr Lynsey Corless, Hull University Teaching Hospitals NHS Trust.
3 minutes – Welcome and Introductions – Dr Forton
10 minute – The Growing Burden of MASH: Epidemiology, Pathophysiology, and Global Impact – Dr Corless
10 minutes – Diagnosis and Risk Stratification of Liver Fibrosis in MASH – Dr Forton
7 minutes – Discussion
